Contact Us
Drug Search Results
More Filters [+]

Azilsartan medoxomil

Alternative Names: azilsartan medoxomil
Latest Update: 2024-12-19
Latest Update Note: Clinical Trial Update

Product Description

Azilsartan medoxomil (Edarbi, Takeda) is a new addition to the ARB class of antihypertensive agents. As an ARB, azilsartan medoxomil selectively inhibits angiotensin II from binding to the angiotensin II type-1 receptor (AT1). This receptor inhibition provides the antihypertensive activity of azilsartan medoxomil because it blocks the pressor effects of angiotensin II. (Sourced from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278144/)

Mechanisms of Action: ARB Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Austria | Bangladesh | Belgium | Canada | Croatia | Czech | Egypt | Estonia | European Medicines Agency | Finland | Greece | Hong Kong | Hungary | Iceland | India | Ireland | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Mexico | Netherlands | Peru | Philippines | Poland | Portugal | Russia | Saudi Arabia | Slovakia | Spain | Sweden | Switzerland | Taiwan | Thailand | Ukraine | United Arab Emirates

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Azilsartan medoxomil

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

09/25/2023

News Article

 Azilsartan Medoxomil Potassium Market Share and Size 2023 Global Industry Growth, Manufacturers Data, Latest Updates, Demand, Regional Outlook 2030

09/12/2023

News Article

 Airport Terminal Sign market report drives growth with market research efforts, depicts industry analysis from 2023 to 2030 with a projected 7.4% CAGR.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions